Meet the Judges

The PMEA judging panel comprises a range of experts with a breadth of knowledge and experience, from pharmaceutical marketing specialists to leading management consultants to top business school academics.

Stephanie Hall – Chair

Stephanie Hall is the CEO and founder of Uptake, a global healthcare consultancy specialising in planning, strategy, capability and launch and recipient of the King’s Award for Enterprise for International Trade. Stephanie has been recognised as one of the UK’s top 10 women entrepreneurs in EY’s Winning Women Entrepreneurs’ programme and won the International category at the National Businesswomen’s awards.

Stephanie has over 25+ years’ experience in marketing, finance, sales roles and consultancy projects in multi-national pharma/biotech companies (GSK, Eli Lilly & Co, Sanofi) and alliance partnerships.

Stephanie speaks regularly at industry conferences and is the author of the Pharma Brand Planners’ blog, Launch Leaders’ blog and Pharma Marketers’ blog in Pharma Market Europe (PME) and pmlive.com.

Stephanie describes herself as strategic, driven, passionate about healthcare marketing and an advocate of women business leaders, international cultures and entrepreneurship.
Simon Bates is Managing Director of Lucid Strategy Consulting, part of the Lucid Communications Group. He works with major global and mid-size biopharma and smaller biotech/healthtech companies on a range of strategy and transformation programs. His recent experience spans go-to-market, commercial innovation, “above molecule” and digital strategies. He has a deep appreciation of the complex healthcare context; its patient, provider & payer systems; and their operational & regulatory frameworks, and how life sciences companies are evolving to support the future of healthcare. He is passionate about re-inventing how organisations across the ecosystem work together to drive value for patients, society and shareholders.
Alice Blezat
Charlie Buckwell has held successful leadership roles across the pharma industry and communications agencies, including leading the development and transformation of the Medical Communications capability at IPG Health, the world’s most awarded health communications network.

With over 35 years in healthcare communications, Charlie’s journey began client-side with AstraZeneca, where he gained invaluable experience in Global Marketing before transitioning agency-side in 2001. He led the growth of Medical Communications at McCann Health and then IPG Health, as well as serving as President of McCann Health EMEA and President of the McCann Health Global Scientific Council, and as a member of the IPG Health Executive Leadership Team.

Charlie is an advocate of public-private partnership in healthcare provision and has a specific interest in programs that close the gap between science and real-life clinical practice, and a passion for fostering supportive and inclusive work environments where people can thrive and excel.

He hold’s an MBA from Lancaster Management School, where he focused on best practice strategy development and intervening in complex organizations and systems.
Jackie Cuyvers is a recognised leader in health-focused social listening and behavioural research, with over 20 years of experience dedicated to advancing healthcare outcomes through innovative insights. As the CEO and Co-Founder of Convosphere, a global social listening consultancy, Jackie has built and led diverse teams of specialists across multiple languages and regions, pioneering new methods in digital research that directly impact public health strategies. Her expertise spans the development and implementation of social listening programs that have shaped global initiatives, particularly in the pharmaceutical and healthcare sectors.
Jackie holds an MBA in Marketing and a Master’s from Oxford in the Social Science of the Internet, grounding her practical expertise in a strong academic foundation. Her work is characterised by a unique ability to translate complex data into actionable strategies, making her a sought-after speaker at industry conferences worldwide. As an advocate for the application of social intelligence in healthcare, Jackie is committed to driving behavioural change through research, ensuring that healthcare organisations are equipped to meet the challenges of today’s digital landscape.
Jackie’s deep understanding of the pharmaceutical industry, combined with her operational acumen and intellectual curiosity, positions her as a pivotal figure in advancing the use of social listening to improve patient outcomes and support the strategic goals of global health organisations.
Andrew Dowd runs the European teams for some of Accenture’s largest global pharmaceutical clients and he leads their Life Sciences industry group in Accenture across the UKI and Ireland. His core expertise lies in supporting his clients on their journey through complex transformation programmes and driving the execution of change across multiple geographies and capabilities. Throughout his career he has been a strong believer in the value that can be created when exceptional people are given the tools, the belief and the opportunity to do their very best work. He is passionate about developing relationships and building teams that strive for excellence and focus on solving complex problems.

Kuntal Fisher is the founder and ex-CEO of FIECON – a B-corp certified pharmaceutical commercialisation company. FIECON is now a part of Herspiegel, and FIECON brings life-changing medicine to the people who need it the most.
Kuntal started FIECON after spending over a decade in both academia as a Geneticist, and as a strategic advisor to the pharmaceutical industry.
Kuntal has been recognised as UK’s one of five EY Entrepreneurial Winning Women in 2021, and has received the “Top 50 Most Ambitious Entrepreneurs” award and was a EY “Entrepreneur of the Year” Finalists in 2023. She also received the “People First” award from The Times in partnership with LDC. Kuntal is also a judge at the EY “Entrepreneur of the Year” program.
In building FIECON, Kuntal built a company that prioritised its people, clients, and society, with a focus on using economics for the good of humanity. At the heart of her purpose lies a steadfast commitment to levelling the playing field in the business world for women. By investing, mentoring, and sharing knowledge, she is dedicated to shaping a more equitable entrepreneurial community. This also seamlessly intertwines with her focus on blending education and entrepreneurship to create a fertile ground for innovation and growth.
Ben Glatz is a Partner in Kearney’s Healthcare and Life sciences team, splitting his time between London and Copenhagen. He has 15+ years of cross industry and consulting experience with a focus on customer centric growth and transformations. At Kearney Ben serves global pharma leaders on commercial strategy and transformation initiatives across therapeutic areas and regions. He specialises in developing differentiated omnichannel strategies and marketing capabilities in collaboration with his clients.
Caroline Gosling is a partner at Rubica: Change & Analytics, an organisational change consultancy focussed on improving people’s experience of work and customers’ experience of organisations. Specialising in culture and capability transformation, with specific expertise in life sciences, Rubica blends organisational excellence, performance measurement and engagement to deliver commercial and human benefit.

Caroline’s 20+ years in the industry, working both in consulting and in a range of roles at GSK, has included corporate and public affairs, marketing, medical education and employee engagement.

She currently partners with organisational leaders (and the teams they are accountable to and for) to diagnose and address the mindset, behavioural, structural and system blockers to delivering on the potential and promise of customer- and patient-centricity. She’s particularly interested in how we re-assess what good looks like in our efforts to be a net-contributor within challenged health and human systems.

Caroline is a Trustee of the Blue Cross, the national pet welfare charity, and is a Fellow of the Royal Society for Arts, Manufactures and Commerce.
Jennifer Lambert is a dynamic and results-driven leader who brings over 25 years of experience in the health and wellness sector, with a deep commitment to driving health equity and transformative outcomes across health communications. Currently, Jennifer is leading Klick EMEA, a global leader in healthcare advertising recognized by LIA’s Global Independent Health Agency of the Year 2023 and 2024. Her focus is to expand its end-to-end services across the EMEA region. Klick’s accolades include being named Cannes Lions’ #3 Global Independent Agency and #2 Global Healthcare Agency
Jennifer is passionate about empowering her teams and clients to reach their highest potential by embracing the “yes, and” mindset—challenging the status quo and encouraging innovative thinking. She thrives on creating novel tools and forward-thinking strategies that not only drive brand success but, more importantly, contribute to healthier outcomes for people around the world.
With a strategic vision and a commitment to health equity, Jennifer also supports multiple charities. Her career continues to be a testament to her belief in the power of collaboration, creativity, and purpose-driven leadership in transforming the health and wellness landscape. Jennifer was shortlisted as Campaign’s Visionary Business Leader in 2023 and has served on a number of Juries including: Campaign Purpose Awards, Adforum Global Awards, Lisbon International Heatlh Awards, Effies Europe, Communique, PMEA Awards and Britain’s Care Awards.
Laura Mace
Laura leads Baringa’s work with leading client organisations to improve their commercial impact – be that through optimising commercial strategy, pricing, or marketing excellence. She has a focus on life sciences but is also a proponent of learning from other industries and thus works across multiple sectors.
Laura has a PhD in Chemistry, and started out her professional career at GSK, where she was a Development Chemist in R&D in Stevenage and Tonbridge.
Lisa McCurdy is a Partner with Osprey Health Consulting, a global strategic marketing consultancy. A Chartered Marketer (and past PMEA winner) with more than 25 years’ experience in Biopharma, Lisa has extensive experience in commercial leadership across multiple therapy areas, from cardio-metabolic to oncology brands, and more recently CAR T therapy. Lisa has led local, regional, and global sales, marketing and operational teams, and champions the power of strategic alignment through all functions and channels. Lisa has a depth of experience leading brand portfolios across brand life cycles and is a firm believer in breaking down functional silos, empowering teams to deliver creative solutions to drive commercial success.

Lisa has a particular interest in the value of diversity, in particular supporting women in pharma leadership through mentorship, coaching and education.

 
Kate Rogers is an independent advisor to the life sciences and pharmaceutical industry. She currently serves as Non-Executive Director for Ixico Plc, a global leader in neuroscience imaging and biomarker analytics, and is former CEO of the Follicular Lymphoma Foundation.

Kate has worked in the Pharma and Life Sciences industry for more than 25 years, much of that time with GSK. She is a proven cross-functional leader with significant commercial, finance and transformation experience. She has expertise in portfolio strategy, commercial partnerships, acquisitions and divestments, and building new capabilities.

Kate is deeply committed to improving human health outcomes through maximising the opportunity of life science and health innovation. She is delighted to be on the judging panel for the 2025 Pharmaceutical Market Excellence Awards.
Paul Simpson is VP of Patient and Market Access at IQVIA UK.

He has extensive pan-European and US experience of pharma/biotech commercialisation and has held senior roles in marketing, sales and general management.

Paul is a staunch advocate of account management, using environmental understanding to derive practical solutions which help clients drive healthcare forward and ultimately lead to better outcomes for patients.
Marc Tiltman is Managing Director of Only The Brave, a strategic healthcare consultancy specialised in supporting product teams to build bold strategies to launch new medicines. Marc has over 25 years of Pharma/Biotech product strategy experience from leading launches at GSK, Sanofi Pasteur MSD and Shire as well as supporting companies through consultancy projects. With broad therapeutic area expertise and a strong international perspective having worked at country, regional and global levels and lived in the UK, France and Switzerland, Marc has a developed passion for aligning teams and organizations behind clear, bold, patient-centric strategy.